Newsletter Signup | Community
Overview of CML Accelerated & Blastic Phases
Copiktra approved by FDA for treatment of CLL and SLL
Venclexta Significantly Reduces Cancer Progression in Chronic Lymphocytic Leukemia
Dr. Kerry Rogers MD of Ohio State discusses Venclexta combination precision medicine treatment for CLL
Chemotherapy in Addition to Interferon May not Improve Survival for Newly Diagnosed CML
Dr Zent M.D. and colleagues report on relationship between leukemia and risk of developing melanoma.